Oryzon to invest eur 20 million to develop new drugs
Catalan Economy
10 Sep 2009
Biotech company oryzon genomics has announced a four-year program to invest eur 20 million in the development of new drugs. oryzon ceo carlos buesa indicated that the company would use the resources to strengthen its research on biomarkers and antibody therapy.
oryzon recently opened its new 2,300-square-meter corporate headquarters in cornellà de llobregat (barcelona), with an investment of eur 2.5 million. the company expects revenue of eur 8 million for its current fiscal year.
source: expansión catalunya, 08/09/09
Related news and success stories.
-
05 Apr 2024
Catalonia launches a new Master's in Semiconductors and Microelectronic Design
-
05 Apr 2024
Barcelona boosts business connectivity with new flights to Miami
-
27 Mar 2024
Catalonia presents the success of its economic cluster policy at Harvard University
-
26 Mar 2024
The children's product sector in Catalonia has a turnover of over €4.4 billion